LCD ID Number: L36186 Status: A-Approved
LCD Title: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
Geographic Jurisdiction: Wyoming Other Jurisdictions
Original Determination Effective Date:
04/19/2016
Original Determination Ending Date:
Revision Effective Date:
07/16/2023
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act (SSA), §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary.
42 CFR §410.32(a) Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions
CMS Internet-Only Manual, Pub. 100-02, Medicare Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|